Research describes methodology for use of digital health technologies in Parkinson's disease clinica
- DHV-NET
- Jul 7, 2023
- 1 min read
Research leaders at CHeT have joined forces with organizations and regulators through C-Path's Critical Path for Parkinson's (CPP) Consortium, a precompetitive public-private partnership. CPP aims to accelerate the regulatory endorsement of digital tools in Parkinson's clinical trials through its Digital Drug Development Tools (3DT) initiative.
